Inspire Medical Systems (INSP) Stock Price

Inspire Medical Systems Price

NYSE·CLOSED
50.21USD+0.19 (+0.38 %)
Market closed

Revenue has compounded at 60.6% per year over the past 10 years to 911.98 M USD. Inspire Medical Systems's net margin stands at 15.9%, up from -18.0% several years earlier. Analysts set a median price target of 132.60 USD, implying 164.1% above the current price. Of 25 analysts, 15 rate the stock a buy — an overall Buy consensus. The stock trades about 26% above its 52-week low.

Inspire Medical Systems stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Inspire Medical Systems over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Inspire Medical Systems stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Inspire Medical Systems's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Inspire Medical Systems Stock Price History
DateInspire Medical Systems Price
7/31/202650.21 USD
7/30/202650.02 USD
7/29/202651.81 USD
7/27/202651.01 USD
7/23/202650.81 USD
7/22/202650.40 USD
7/21/202652.49 USD
7/20/202653.27 USD
7/17/202650.60 USD
7/16/202651.54 USD
7/15/202650.50 USD
7/14/202649.15 USD
7/13/202651.13 USD
7/10/202651.76 USD
7/9/202651.52 USD
7/8/202646.78 USD
7/7/202650.08 USD
7/6/202647.11 USD
7/2/202646.95 USD
7/1/202645.46 USD
6/30/202644.61 USD
6/29/202644.50 USD
6/26/202645.72 USD
6/25/202643.45 USD
6/24/202643.20 USD
6/23/202641.75 USD
6/22/202642.15 USD
6/18/202641.60 USD
6/17/202642.47 USD
6/16/202641.75 USD
6/15/202642.10 USD
6/12/202643.51 USD
6/11/202642.15 USD
6/10/202642.66 USD
6/9/202642.21 USD
6/8/202641.94 USD
6/5/202641.85 USD
6/4/202641.38 USD
6/3/202639.80 USD
6/2/202640.67 USD
6/1/202641.68 USD
5/29/202642.65 USD
5/28/202643.39 USD
5/27/202641.74 USD
5/26/202642.56 USD
5/22/202643.23 USD
5/21/202643.79 USD
5/20/202643.10 USD
5/19/202642.53 USD
5/18/202641.83 USD
5/15/202640.05 USD
5/14/202642.66 USD
5/13/202641.92 USD
5/12/202644.06 USD
5/11/202643.35 USD
5/8/202644.26 USD
5/7/202645.57 USD
5/6/202645.70 USD
5/5/202648.25 USD
5/4/202654.84 USD
5/1/202656.70 USD
4/30/202656.14 USD
4/29/202653.41 USD
4/28/202655.11 USD
4/27/202655.07 USD
4/24/202656.31 USD
4/22/202654.20 USD
4/21/202652.03 USD
4/20/202656.97 USD
4/17/202657.59 USD
4/16/202656.45 USD
4/15/202656.64 USD
4/14/202656.83 USD
4/13/202654.92 USD
4/10/202654.02 USD
4/9/202656.69 USD
4/8/202653.38 USD
4/7/202654.42 USD
4/6/202654.14 USD
4/2/202654.99 USD
4/1/202653.64 USD
3/31/202651.58 USD
3/30/202650.41 USD
3/27/202650.13 USD
3/26/202650.45 USD
3/25/202651.41 USD
3/24/202652.07 USD
3/23/202652.16 USD
3/20/202653.72 USD
3/19/202654.68 USD
3/18/202656.40 USD
3/17/202655.15 USD
3/16/202658.87 USD
3/13/202658.62 USD
3/12/202658.25 USD
3/11/202659.97 USD
3/10/202659.44 USD
3/9/202661.89 USD
3/6/202662.99 USD
3/5/202662.46 USD
3/4/202664.32 USD
3/3/202665.80 USD
3/2/202664.81 USD
2/27/202664.51 USD
2/26/202668.05 USD
2/25/202659.25 USD
2/24/202657.72 USD
2/23/202658.29 USD
2/20/202659.53 USD
2/19/202659.78 USD
2/18/202661.90 USD
2/17/202660.39 USD
2/13/202659.76 USD
2/12/202659.65 USD
2/11/202668.21 USD
2/10/202668.14 USD
2/9/202666.33 USD
2/6/202665.70 USD
2/5/202665.60 USD
2/4/202668.23 USD
2/3/202672.10 USD
2/2/202673.45 USD
1/30/202675.78 USD
1/29/202678.54 USD
1/28/202682.01 USD
1/27/202681.79 USD
1/26/202681.33 USD
1/23/202679.40 USD
1/22/202680.81 USD
1/21/202696.20 USD
1/20/202694.45 USD
1/16/202692.23 USD
1/15/202696.47 USD
1/14/202693.05 USD
1/13/202692.46 USD
1/12/202696.93 USD
1/9/202698.38 USD
1/8/202695.00 USD
1/7/202699.03 USD
1/6/202697.21 USD
1/5/202694.76 USD
1/2/202692.27 USD
12/31/202592.23 USD
12/30/202592.57 USD
12/29/202593.67 USD
12/26/202595.47 USD
12/24/202595.65 USD
12/23/202594.98 USD
12/22/202597.93 USD
12/19/202596.54 USD
12/18/202595.27 USD
12/17/2025118.27 USD
12/16/2025115.51 USD
12/15/2025119.26 USD
12/12/2025130.68 USD
12/11/2025137.37 USD
12/10/2025140.07 USD
12/9/2025140.53 USD
12/8/2025143.99 USD
12/5/2025136.81 USD
12/4/2025140.03 USD
12/3/2025134.75 USD
12/2/2025133.93 USD
12/1/2025126.34 USD
11/28/2025124.41 USD
11/26/2025127.33 USD
11/25/2025130.39 USD
11/24/2025117.29 USD
11/21/202589.87 USD
11/20/202583.27 USD
11/19/202583.43 USD
11/18/202583.57 USD
11/17/202584.87 USD
11/14/202586.35 USD
11/13/202586.78 USD
11/12/202590.91 USD
11/11/202590.59 USD
11/10/202586.07 USD
11/7/202581.79 USD
11/6/202583.81 USD
11/5/202582.82 USD
11/4/202585.01 USD
11/3/202573.71 USD
10/31/202572.08 USD
10/30/202573.07 USD
10/29/202575.17 USD
10/28/202577.17 USD
10/27/202578.20 USD
10/24/202577.52 USD
10/23/202580.17 USD
10/22/202581.59 USD
10/21/202582.79 USD
10/20/202580.80 USD
10/17/202578.01 USD
10/16/202577.34 USD
10/15/202578.84 USD
10/14/202578.84 USD
10/13/202577.68 USD
10/10/202575.17 USD
10/9/202580.14 USD
10/8/202578.54 USD
10/7/202576.82 USD
10/6/202576.37 USD
10/3/202576.58 USD
10/2/202574.09 USD
10/1/202572.38 USD
9/30/202574.20 USD
9/29/202575.61 USD
9/26/202577.24 USD
9/25/202577.32 USD
9/24/202577.83 USD
9/23/202577.04 USD
9/22/202578.53 USD
9/19/202579.88 USD
9/18/202583.40 USD
9/17/202580.00 USD
9/16/202580.80 USD
9/15/202580.74 USD
9/12/202580.05 USD
9/11/202582.80 USD
9/10/202578.77 USD
9/9/202581.47 USD
9/8/202583.55 USD
9/5/202586.46 USD
9/4/202586.32 USD
9/3/202585.60 USD
9/2/202594.51 USD
8/29/202593.69 USD
8/28/202591.46 USD
8/27/202592.30 USD
8/26/202591.75 USD
8/25/202592.92 USD
8/22/202595.99 USD
8/21/202591.62 USD
8/20/202593.05 USD
8/19/202590.06 USD
8/18/202588.34 USD
8/15/202587.77 USD
8/14/202584.58 USD
8/13/202587.36 USD
8/12/202583.93 USD
8/11/202579.63 USD
8/8/202579.14 USD
8/7/202577.05 USD
8/6/202578.45 USD
8/5/202587.91 USD
Access this data via the Eulerpool API
Get Free API Key

Inspire Medical Systems Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
624.80 M USD
-40.27 M USD
-21.15 M USD
Jan 1, 2024
802.80 M USD
36.08 M USD
53.51 M USD
Jan 1, 2025
911.98 M USD
50.95 M USD
145.42 M USD
Jan 1, 2026 (e)
843.33 M USD
275.16 M USD
26.24 M USD
Jan 1, 2027 (e)
875.64 M USD
285.70 M USD
35.98 M USD
Jan 1, 2028 (e)
941.83 M USD
307.30 M USD
54.05 M USD
Jan 1, 2029 (e)
1.07 B USD
349.31 M USD
76.14 M USD
Jan 1, 2030 (e)
1.18 B USD
383.70 M USD
106.07 M USD

Inspire Medical Systems Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 6:10 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
0.010.020.030.050.080.120.230.410.620.800.910.840.880.941.071.18
–100.0075.0078.5764.0040.24102.6174.6853.3228.5313.59-7.463.807.5413.719.91
62.5075.0078.5780.0082.9384.3585.8483.7884.6284.6685.4085.4085.4085.4085.4085.40
0.010.010.020.040.070.100.200.340.530.680.780.720.750.800.911.00
-19.00-17.00-15.00-20.00-34.00-56.00-39.00-47.00-40.0036.0050.00275.00285.00307.00349.00383.00
-237.50-106.25-53.57-40.00-41.46-48.70-16.74-11.55-6.414.495.4932.6232.5732.6232.6232.57
-21.00-18.00-17.00-21.00-33.00-57.00-42.00-44.00-21.0053.00145.0026.0035.0054.0076.00106.00
–-14.29-5.5623.5357.1472.73-26.324.76-52.27-352.38173.58-82.0734.6254.2940.7439.47
29.221.0012.4621.8324.0726.9827.3730.2130.2430.7529.2229.2229.2229.2229.2229.22
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Inspire Medical Systems generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Inspire Medical Systems retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Inspire Medical Systems's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Inspire Medical Systems has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Inspire Medical Systems's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Inspire Medical Systems stock margins

The Inspire Medical Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Inspire Medical Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Inspire Medical Systems.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
85.74 %
-17.12 %
-18.01 %
Jan 1, 2022
83.79 %
-11.67 %
-11.00 %
Jan 1, 2023
84.54 %
-6.45 %
-3.39 %
Jan 1, 2024
84.68 %
4.49 %
6.67 %
Jan 1, 2025
85.39 %
5.59 %
15.95 %
Jan 1, 2026 (e)
85.39 %
32.63 %
3.11 %
Jan 1, 2027 (e)
85.39 %
32.63 %
4.11 %
Jan 1, 2028 (e)
85.39 %
32.63 %
5.74 %

Inspire Medical Systems Stock Revenue, EBIT, Earnings per Share

The Inspire Medical Systems earnings per share therefore indicates how much revenue Inspire Medical Systems has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
8.53 USD
-1.46 USD
-1.54 USD
Jan 1, 2022
13.50 USD
-1.58 USD
-1.49 USD
Jan 1, 2023
20.66 USD
-1.33 USD
-0.70 USD
Jan 1, 2024
26.11 USD
1.17 USD
1.74 USD
Jan 1, 2025
31.21 USD
1.74 USD
4.98 USD
Jan 1, 2026 (e)
29.02 USD
9.42 USD
0.90 USD
Jan 1, 2027 (e)
30.13 USD
9.78 USD
1.24 USD
Jan 1, 2028 (e)
32.41 USD
10.52 USD
1.86 USD

Inspire Medical Systems business model & stock analysis

Inspire Medical Systems Inc. is an American medical technology company that was founded in 2007 in Maple Grove, Minnesota. It focuses primarily on the development and production of implantable medical devices used in the treatment of sleep apnea. The company's business model is based on manufacturing and selling implantable devices, which are used by specially trained doctors. Inspire offers a comprehensive training program to educate doctors on the use of their devices and ensure optimal patient treatment. The company has had an impressive success story since its founding, with significant investments in research and development and the attainment of several patents. In summary, Inspire Medical Systems Inc. is an innovative company dedicated to the development and production of implantable medical devices for the treatment of sleep apnea. Its wide range of products and services aim to support doctors and patients, and the company is on track to become a leading provider in the industry.

Inspire Medical Systems SWOT Analysis

Strengths

Inspire Medical Systems Inc possesses several strengths that contribute to its success and competitive advantage in the market:

  • Innovative and patented technology
  • Highly effective treatment for obstructive sleep apnea
  • Significant reduction in healthcare costs through long-term treatment benefits
  • Strong relationships with healthcare professionals and key opinion leaders
  • Robust sales and distribution network

Weaknesses

Despite its strengths, Inspire Medical Systems Inc faces certain weaknesses that it should address to maintain its market position:

  • Relatively high cost of treatment compared to alternative therapies
  • Dependency on reimbursement policies and insurance coverage
  • Limited market penetration in certain geographic regions
  • Requires a surgical procedure for permanent implantation
  • Need for ongoing patient compliance and follow-up

Opportunities

There are several opportunities that Inspire Medical Systems Inc can capitalize on to drive growth and expand its market presence:

  • Increasing prevalence of obstructive sleep apnea globally
  • Emerging markets with untapped potential for sleep apnea treatment
  • Technological advancements improving the efficacy and affordability of treatment
  • Partnerships with healthcare providers to enhance awareness and adoption
  • Expanding product portfolio to address related sleep disorders

Threats

Inspire Medical Systems Inc faces certain threats that may hinder its growth and competitive position:

  • Intense competition from alternative therapies and medical devices
  • Regulatory challenges and compliance requirements
  • Economic uncertainties impacting healthcare spending
  • Shifts in reimbursement policies and insurance coverage
  • Potential side effects or complications associated with the treatment

Inspire Medical Systems Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Inspire Medical Systems Employees
Details
Date
Inspire Medical Systems Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Inspire Medical Systems Segments

Inspire Medical Systems Revenue by Segment

  • Max

Operating Segment
Details
Date
Operating Segment
Jan 1, 2024
802.80 M USD
Jan 1, 2025
911.98 M USD

Inspire Medical Systems Revenue by Region

  • 3 Years

  • 5 Years

  • Max

United States
All other countries
Europe
Details
Date
United States
All other countries
Europe
Jan 1, 2018
44.38 M USD
0.00 USD
6.22 M USD
Jan 1, 2019
73.66 M USD
0.00 USD
8.39 M USD
Jan 1, 2020
106.11 M USD
0.00 USD
9.27 M USD
Jan 1, 2021
220.98 M USD
12.42 M USD
0.00 USD
Jan 1, 2022
394.83 M USD
13.02 M USD
0.00 USD
Jan 1, 2023
606.18 M USD
18.62 M USD
0.00 USD
Jan 1, 2024
771.04 M USD
31.76 M USD
0.00 USD
Jan 1, 2025
872.09 M USD
39.90 M USD
0.00 USD

Inspire Medical Systems Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Inspire Medical Systems historical P/E ratio, EBIT multiple, and P/S ratio

Inspire Medical Systems annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Inspire Medical Systems shares outstanding

The number of shares of Inspire Medical Systems was 29.22 M in 2025. This indicates how many shares Inspire Medical Systems is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
27.37 M Stocks
Jan 1, 2022
30.21 M Stocks
Jan 1, 2023
30.24 M Stocks
Jan 1, 2024
30.75 M Stocks
Jan 1, 2025
29.22 M Stocks
Jan 1, 2026 (e)
29.22 M Stocks
Jan 1, 2027 (e)
29.22 M Stocks
Jan 1, 2028 (e)
29.22 M Stocks

Current Inspire Medical Systems forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
5.45 %
Buy
60.00 % (15)
Hold
40.00 % (10)
Sell
0.00 % (0)
12M Price Target
132.60
Last Price
63.76
Currency
USD
12M Return Potential
107.95 %
LTM Return
0 %

Inspire Medical Systems Analyst Rating Actions

DateFirmActionRatingReliability
7/16/2026
Truist Securities
Truist Securities
MaintainedHold–
6/23/2026
Evercore ISI Group
Evercore ISI Group
DowngradeOutperformIn Line62
5/7/2026
Oppenheimer
Oppenheimer
MaintainedPerform65
5/5/2026
Wells Fargo
Wells Fargo
MaintainedEqual Weight56
5/5/2026
Truist Securities
Truist Securities
MaintainedHold–
5/5/2026
Stifel
Stifel
MaintainedBuy–
5/5/2026
RBC Capital
RBC Capital
MaintainedSector Perform52
5/5/2026
Piper Sandler
Piper Sandler
DowngradeOverweightNeutral51
5/5/2026
Mizuho
Mizuho
MaintainedOutperform31
5/5/2026
JP Morgan
JP Morgan
MaintainedNeutral80

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Inspire Medical Systems Earnings Calls

2025

Inspire Medical Systems Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/3/2026-0.28USD-198.59 MUSD-2026 Q2
5/4/2026-0.25USD-206.50 MUSD-2026 Q1
2/11/20260.89USD-270.60 MUSD-2025 Q4
4/30/2024-0.51USD-169.49 MUSD-2024 Q1
2/5/2024-0.22USD-181.50 MUSD-2023 Q4
7/31/2023-0.74USD-123.23 MUSD-2023 Q2
5/1/2023-1.01USD-102.82 MUSD-2023 Q1
2/6/2023-0.69USD-118.59 MUSD-2022 Q4
11/1/2022-0.78USD-95.73 MUSD-2022 Q3
8/2/2022-0.63USD-79.45 MUSD-2022 Q2

EESG©

Eulerpool ESG Scorecard© for the Inspire Medical Systems stock

54/100
38
Environment
78
Social
46
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees49
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Inspire Medical Systems shareholder structure

% Name
12.21457%
BLACKROCK, INC.
BLACKROCK, INC.
9.30226%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
8.72661%
WELLINGTON MANAGEMENT GROUP LLP
WELLINGTON MANAGEMENT GROUP LLP
5.63377%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
4.99186%
MORGAN STANLEY
MORGAN STANLEY
4.35904%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
...

Inspire Medical Systems Beneficial Ownership Filings (SEC 13D/G)

Free Float
94.3%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
11.30%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗
11.04%
Abigail P. Johnson
Abigail P. Johnson
SEC ↗
9.36%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
8.80%
Wellington Management Group LLP
Wellington Management Group LLP
SEC ↗
8.20%
KPCB XII Associates, LLC
KPCB XII Associates, LLC
SEC ↗
8.10%
Kleiner Perkins Caufield & Byers XII, LLC (“KPCB XII”)
Kleiner Perkins Caufield & Byers XII, LLC (“KPCB XII”)
SEC ↗
7.99%
OrbiMed Capital GP V LLC
OrbiMed Capital GP V LLC
SEC ↗
7.00%
MICHAEL D. KAZMA
MICHAEL D. KAZMA
SEC ↗
7.00%
JOYCE ERONY
JOYCE ERONY
SEC ↗
7.00%
ANDERS HOVE
ANDERS HOVE
SEC ↗

Inspire Medical Systems Executives and Management Board

19 members · avg. age 58 · 32 % women

TH

Mr. Timothy Herbert (62)

Chairman of the Board, President, Chief Executive Officer · since 2007

8.11 M USD

Management

CW

Mr. Carlton Weatherby (40)

Chief Strategy and Growth Officer

2.90 M USD
RB

Mr. Randall Ban (60)

Executive Vice President - Patient Access and Therapy Development · since 2025

2.85 M USD
BP

Mr. Bryan Phillips (53)

Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary

2.83 M USD
RB

Mr. Richard Buchholz (57)

Chief Financial Officer

2.82 M USD
JR

Mr. John Rondoni (45)

Chief Technology Officer

2.11 M USD
MM

Ms. Melissa Mann (49)

Chief People Officer

–

Board of Directors

GE

Mr. Gary Ellis (68)

Lead Independent Director

266,187.00 USD
SM

Mr. Shawn Mccormick (60)

Independent Director

250,000.00 USD
DM

Mr. Dana Mead (65)

Independent Director

246,216.00 USD
SB

Ms. Shelley Broader (60)

Independent Director

245,000.00 USD
GG

Ms. Georgia Garinoismelenikiotou (65)

Independent Director

240,000.00 USD
CB

Ms. Cynthia Burks (59)

Independent Director

237,500.00 USD

Frequently asked questions about Inspire Medical Systems

The business model of Inspire Medical Systems Inc revolves around providing innovative solutions for obstructive sleep apnea (OSA) treatment. The company specializes in the development and commercialization of advanced medical devices, particularly the Inspire therapy system. This implantable device delivers mild electrical stimulation to the hypoglossal nerve, keeping the airway open during sleep and effectively reducing OSA symptoms. Through its unique business model, Inspire Medical Systems aims to improve the quality of life for individuals with sleep apnea by offering a breakthrough treatment option that can significantly alleviate symptoms and enhance overall sleep health.

Inspire Medical Systems Inc is primarily active in the medical device industry.

The main competitors of Inspire Medical Systems Inc in the market include Medtronic, Inc., Intuitive Surgical, Inc., ResMed Inc., and Fisher & Paykel Healthcare Corporation Limited.

Inspire Medical Systems Inc, a renowned medical technology company, was founded in 2007 by Professor Philip R. Westbrook and Dr. Timothy A. Meyer. The company is headquartered in Maple Grove, Minnesota, USA. Inspire Medical Systems is dedicated to developing innovative solutions for the treatment of obstructive sleep apnea (OSA). The company introduced the Inspire therapy, an FDA-approved neurostimulation technology that provides a safe and effective alternative to traditional OSA treatments. With a mission to enhance the quality of life for patients suffering from OSA, Inspire Medical Systems has gained recognition as a leader in the field of sleep apnea treatment solutions.

Some significant milestones achieved by Inspire Medical Systems Inc include the successful completion of multiple clinical trials and obtaining FDA approval for their innovative Inspire therapy. The company has also undergone successful IPOs and has expanded its market presence globally. Moreover, Inspire Medical Systems Inc has received numerous awards and recognitions for their revolutionary advancements in the treatment of obstructive sleep apnea. These milestones showcase the company's commitment to innovation, improving patient outcomes, and establishing itself as a leader in the medical technology industry.

Inspire Medical Systems Inc primarily operates in the United States and Europe. The company's innovative products and therapies are focused on treating obstructive sleep apnea (OSA). Through their unique airway stimulation technology, Inspire Medical Systems Inc provides solutions to help patients with OSA improve their sleep quality and overall well-being. With a strong presence in these key regions, Inspire Medical Systems Inc continues to expand its reach and provide effective treatment options for individuals suffering from sleep apnea.

Inspire Medical Systems Inc represents a commitment to improving the lives of individuals suffering from sleep apnea. Their corporate philosophy revolves around innovation, patient-centricity, and delivering effective and reliable solutions. By combining advanced technology with clinical expertise, Inspire Medical Systems Inc offers an innovative therapy that provides significant benefits to patients. The company emphasizes quality and excellence in everything they do, ensuring that their products meet the highest standards in terms of effectiveness and patient safety. With their dedication to improving the lives of those affected by sleep apnea, Inspire Medical Systems Inc strives to be a leader in the field of medical device solutions.

Analysts currently set an average price target of 131.09 USD for the Inspire Medical Systems stock (median: 132.60 USD), implying +105.6 % versus the latest price. The consensus is based on 25 analyst ratings.

Inspire Medical Systems Analyst Price Targets 2026

25 analysts currently rate the Inspire Medical Systems stock: 15 recommend buying, 10 holding and 0 selling. For 2026, analysts expect Inspire Medical Systems to generate revenue of 843.33 M USD and earnings per share of 0.90 USD.

Inspire Medical Systems Analyst Price Targets 2026

Converted at the current exchange rate, the Inspire Medical Systems share trades at 43.56 EUR (50.21 USD).

The Inspire Medical Systems share (INSP) is listed on 3 stock exchanges, including: NYSE (INSP), Frankfurt (2DR.F), München (2DR.MU).

Inspire Medical Systems Inc is a leading provider of innovative medical products for the treatment of sleep apnea. The company is headquartered in Minneapolis, MN and was founded in 2007. It is listed on the New York Stock Exchange (NYSE: INSP). Inspire Medical Systems offers an innovative therapy that uses selective neurostimulation to open the patient's airways during sleep and regulate breathing. The Inspire system consists of a small, implantable stimulation unit that is attached to the chest muscle, a sensor implanted in the chest muscle, and a remote control that the patient uses to turn the system on and off. The company holds a variety of patents in this field and works closely with leading doctors and sleep experts to ensure the effectiveness and safety of the system. The Inspire system is currently available in the United States, Canada, and Europe. In addition to the main product of the Inspire system, the company also offers a variety of therapy and support services to help patients with their sleep apnea treatment. These services include telephone support, training programs, and assistance with billing. Inspire Medical Systems' business model is based on a highly focused market approach. The company targets patients who suffer from severe sleep apnea and have not had success with conventional treatment methods, such as CPAP therapy. Based on market research data, the company estimates that there are up to 2 million potential patients in the US alone who could benefit from the Inspire system. Inspire Medical Systems has also focused on an intensive sales strategy. The company has built a distribution structure that aims to collaborate closely with sleep centers to promote the adoption and use of the system. An important part of this strategy is training doctors and medical staff to ensure they are familiar with the system and can apply it correctly. In terms of financial performance, Inspire Medical Systems has solid indicators. In 2019, the company reported revenue of $162.5 million, a 65% increase from the previous year. The company's success is also reflected in its market capitalization, which is approximately $4 billion. Overall, the business model of Inspire Medical Systems is highly focused and targeted towards a niche in the healthcare market. The company has developed an innovative product and is intensifying its efforts to penetrate the market and promote the use of its system.

The expected revenue of Inspire Medical Systems is 843.33 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Inspire Medical Systems is 26.24 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Inspire Medical Systems is currently 55.91. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Inspire Medical Systems stock.

The price-to-sales ratio (P/S) of Inspire Medical Systems is currently 1.74. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Inspire Medical Systems stock.

The Eulerpool Quality Score for Inspire Medical Systems is 7/10.

The ISIN of Inspire Medical Systems is US4577301090. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Inspire Medical Systems is A2JLEP. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Inspire Medical Systems is INSP. The ticker symbol is used to trade Inspire Medical Systems shares on the stock exchange.

Inspire Medical Systems paid dividends every year for the past 0 years.

Inspire Medical Systems is assigned to the 'Health' sector.

The dividends of Inspire Medical Systems are distributed in USD.

All fundamentals and in-depth analysis of Inspire Medical Systems

Our stock analysis for Inspire Medical Systems stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inspire Medical Systems. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Inspire Medical Systems Stock
Inspire Medical Systems Revenue→
Inspire Medical Systems Stock
Inspire Medical Systems Net Income→
Inspire Medical Systems Stock
Inspire Medical Systems P/E→
Inspire Medical Systems Stock
Inspire Medical Systems P/S→
Inspire Medical Systems Stock
Inspire Medical Systems EBIT→
Inspire Medical Systems Stock
Inspire Medical Systems Dividend→
Inspire Medical Systems Stock
Inspire Medical Systems Directors Dealings→
Inspire Medical Systems Stock
Inspire Medical Systems Stocks→
Inspire Medical Systems Stock
Inspire Medical Systems Market capitalization→
Inspire Medical Systems Stock
Inspire Medical Systems Debt→
Inspire Medical Systems Stock
Inspire Medical Systems Liabilities→
Inspire Medical Systems Stock
Inspire Medical Systems Equity→
Inspire Medical Systems Stock
Inspire Medical Systems AAQS→
Inspire Medical Systems Stock
Inspire Medical Systems Employees→
Inspire Medical Systems Stock
Inspire Medical Systems ROE→
Inspire Medical Systems Stock
Inspire Medical Systems ROA→
Inspire Medical Systems Stock
Inspire Medical Systems ROCE→
Inspire Medical Systems Stock
Inspire Medical Systems News→
Inspire Medical Systems Stock
Inspire Medical Systems Analyst Price Targets→

Health Stocks

InspireMDInspire IVF PCLInstituto de DiagnosticoInspiration Healthcare GroupInsuletInspira Technologies Oxy BHNIntai TechnologyInspecs GroupIntco Medical Technology CoInsmedIntech BiopharmInsight Molecular DiagnosticsAll Stocks A–Z →